| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | DBV Technologies | 456,893 | 29,018,000 | 25.19% | ||
| 2 | HERON THERAPEUTICS INC | 1,095,734 | 20,808,000 | 18.07% | ||
| 3 | COHERUS BIOSCIENCES INC COM | 611,010 | 12,972,000 | 11.26% | ||
| 4 | LIPOCINE INC NEW | 849,921 | 8,627,000 | 7.49% | ||
| 5 | Anacor Pharmaceuticals Inc | 140,756 | 7,523,000 | 6.53% | ||
| 6 | AVALANCHE BIOTECHNOLOGIES IN | 1,102,735 | 5,701,000 | 4.95% | ||
| 7 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 5,520,000 | 4.79% | ||
| 8 | ZAFGEN INC COM | 602,114 | 4,022,000 | 3.49% | ||
| 9 | OCERA THERAPEUTICS INC | 796,550 | 2,342,000 | 2.03% | ||
| 10 | AKARI THERAPEUTICS PLC | 158,352 | 2,217,000 | 1.92% | ||
| 11 | AXOVANT SCIENCES LTD | 184,110 | 2,114,000 | 1.84% | ||
| 12 | ALCOBRA LTD | 484,500 | 1,836,000 | 1.59% | ||
| 13 | Ascendis Pharma | 90,000 | 1,670,000 | 1.45% | ||
| 14 | ARCA biopharma Inc | 462,399 | 1,605,000 | 1.39% | ||
| 15 | BIOCRYST PHARMACEUTICALS | 562,943 | 1,593,000 | 1.38% | ||
| 16 | BEIGENE LTD | 51,000 | 1,495,000 | 1.30% | ||
| 17 | Cynapsus Therapeutics Inc | 108,575 | 1,317,000 | 1.14% | ||
| 18 | EDGE THERAPEUTICS INC | 135,000 | 1,235,000 | 1.07% | ||
| 19 | GLOBAL BLOOD THERAPEUTICS IN COM | 72,990 | 1,158,000 | 1.01% | ||
| 20 | CYTOMX THERAPEUTICS INC COM | 64,200 | 828,000 | 0.72% | ||
| 21 | STEMLINE THERAPEUTICS INC | 135,420 | 631,000 | 0.55% | ||
| 22 | REGENXBIO INC COM | 52,500 | 567,000 | 0.49% | ||
| 23 | ProNAi Therapeutics, Inc. | 56,056 | 378,000 | 0.33% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017146, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
